To encourage these system shifts, the final article in the series discusses how our approach to monitoring, evaluation, and learning has evolved to encourage ... But we know it’s worth it when we see ...
Gilead Sciences, Inc. today announced The New England Journal of Medicine (NEJM) published the full results from the company's pivotal Phase 3 PURPOSE 2 trial evaluating twice-yearly lenacapavir for ...
Fatigued truck drivers are a significant threat on the road, leading to devastating crashes and serious injuries. Orleans Parish has seen its share of traffic t ...